Site Map

Below is an organised list of all the pages on this website. It is a simple way to access any page in two clicks.

Main

• Home
• Contact

Chapters (you must login to view these pages)

• Introduction
  • Why this module is needed
  • CKD Forum
• CKD - Why it has become an important issue
  • Introduction
  • Overview
  • NICE guidance on CKD
  • Prevalence of CKD
  • Further reading
• Physiology of the kidney in health and CKD
  • Introduction
  • Anatomy
  • Renal Pathophysiology
    • Filtration of waste products
    • Tubular function
    • Blood Pressure Control
    • Hormonal functions
    • Uraemia
• Causes of CKD
  • Introduction
  • General and specific disease
  • Hypertension
  • Renovascular Disease
  • Diabetic Nephropathy
  • Obstructive Uropathy
  • Reflux nephropathy/Chronic pyelonephritis
  • Chronic glomerulonephritis
  • Adult polycystic kidney disease
• Measurement of kidney function and proteinuria
  • Introduction
  • Glomerular filtration rate
    • Measurement of GFR using exogenous substances
    • The concept of clearance
    • Measurement of GFR using endogenous substances
  • Proteinuria
    • Albuminuria
• Medicines Management
  • Introduction
  • General principles
  • Guidance for prescribing in CKD
  • Safe prescribing in CKD
  • Antihypertensives
    • ACE Inhibitors (ACE-I)
    • Angiotensin II receptor blockers (ARBs)
    • Thiazide and Thiazide-like Diuretics
    • Loop Diuretics
    • Calcium Channel Blockers (CCBs)
    • β blockers
    • α receptor antagonists
    • Potassium Sparing Diuretics
  • Antimicrobials
    • Nitrofurantoin
    • Macrolides
    • Quinolones
    • Antivirals
    • Trimethoprim
    • Penicillins and cephalosporins
    • Other agents
  • Analgesics
    • NSAIDs
    • Opioid analgesics
    • Neuroleptics for pain relief
  • Antidepressants
  • Diabetes
    • Insulin
    • Metformin
    • Sulfphonylureas
  • LMW heparin
  • Bisphosphonates
  • Cholesterol
    • Statins
    • Fibrates
    • Ezetimibe
  • Vaccinations
  • End of life
• Management of hypertension
  • Introduction
  • Assessment patients with hypertension and CKD
  • Choice of drugs to treat hypertension in CKD
  • Blood Pressure Targets in CKD
  • Management of Hypertension in patients with CKD
  • Using ACE-I or ARBs safely in hypertensive CKD patients
• Nutrition
  • Introduction
  • Healthy Eating in CKD
  • Weight Management
  • Undernutrition
  • Hypertension
    • Sodium
    • Physical Activity
    • Alcohol
  • Diabetes
    • Glycaemic Control
    • Metabolic Syndrome
  • Dietary Protein Intake
  • Phosphate
    • Phosphate Binders
  • Potassium
  • Accessing Information
• What to tell patients
  • Introduction
  • What to tell patients
  • How to encourage patients to help themselves (self-management)
  • Self-monitoring of Blood Pressure
  • If the patient needs to be referred to the renal team
  • Resources
• Primary care
  • Introduction
  • Identification of patients with CKD in Primary Care
  • Prevalence of CKD in the Community
  • Screening for CKD
  • At-risk groups
  • CKD and QOF
  • Results of QOF
  • CKD, Age and QOF
  • Why is it so important to identify and manage CKD patients in Primary care
  • Increased CVD Risk
  • Estimating CVD risk in CKD patients
  • What are the appropriate investigations when following up CKD patients in Primary Care
  • Who should be referred to Secondary Care
  • What do you tell the patient
  • What can the patient do
  • Immunisation and CKD
• Issues for the future
  • Introduction
  • Overview
  • Influencing policy
  • Raising public awareness
  • Professional support and education
  • Improving systems of delivering care
• Acknowledgements
• Glossary
  • α receptor antagonists
  • β blockers
  • ACE Inhibitors (ACE-I)
  • Albumin
  • Aminoglycosides
  • Angiotensin II receptor blockers (ARBs)
  • Antidepressants
  • Arterial hyalinosis(Hyaline arteriosclerosis)
  • Atheroma
  • Bladder outflow obstruction due to prostatic enlargement
  • Blood flow
  • Calcium Channel Blockers (CCBs)
  • Causes of CKD
  • Cholesterol embolisation
  • Chronic glomerulonephritis
  • Chronic tubulointerstitial nephritis
  • Complement components
  • Cyst
  • Cystitis
  • DMSA
  • eGFR
  • Flash pulmonary oedema
  • Focal segmental glomerulosclerosis (FSGS)
  • Glomerular basement membrane
  • Glomerulosclerosis
  • Glomerulus
  • IgA nephropathy
  • Immune complexes
  • Immunoglobulins
  • Impaired renal salt excretion
  • Incompetence of the vesicoureteric valves
  • LMW heparin
  • Loop diuretics
  • Measuring urinary ACR
  • Membranoproliferative glomerulonephritis
  • Membranous glomeroulonephritis
  • Narcotic analgesics
  • NSAIDs
  • Obstruction on renal ultrasound
  • Profibrotic mediators
  • Prostatic carcinoma
  • Pyelonephritis
  • QOF
  • Renal cortical scarring
  • Renal scarring
  • Renal ultrasound
  • Renin-angiotensin system
  • Stages
  • Sulphonylureas
  • Systemic microangiopathy
  • Thiazides
  • Trimethoprim
  • Tubular atrophy
  • Urine dipstick
  • Vascular tissue in the kidneys
  • Vasculitis
• Contact

User

Help

• Accessibility
• Site Help
• Site Map